Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Brivaracetam-D3 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Manufacturer: MilliporeSigma Supelco B0631ML
Description
An internal standard suitable for GC/MS or LC/MS applications in brivaracetam testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Brivaracetam is an antiepileptic drug for the treatment of partial-onset seizures. The drug is marketed under the trade name Briviact™.Specifications
67-56-1 | |
MFCD00055143 | |
100 μg/mL in methanol | |
Ampule | |
1 mL |
C11H17D3N2O2 | |
UN 1230 - class 3 - PG 2 - Methanol, solution | |
215.31 | |
-20°C | |
9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation